Ariel Rechtman

640 total citations
25 papers, 374 citations indexed

About

Ariel Rechtman is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Ariel Rechtman has authored 25 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 7 papers in Neurology and 7 papers in Neurology. Recurrent topics in Ariel Rechtman's work include Multiple Sclerosis Research Studies (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Peripheral Neuropathies and Disorders (5 papers). Ariel Rechtman is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Peripheral Neuropathies and Disorders (5 papers). Ariel Rechtman collaborates with scholars based in Israel, United States and Switzerland. Ariel Rechtman's co-authors include Adi Vaknin‐Dembinsky, Omri Zveik, Livnat Brill, Alaina Borden, J. Gershon‐Cohen, Netta Levin, Esther Oiknine‐Djian, Catarina Raposo, Dana G. Wolf and Iris Lavon and has published in prestigious journals such as Neurology, Journal of Bone and Joint Surgery and Annals of Neurology.

In The Last Decade

Ariel Rechtman

22 papers receiving 363 citations

Peers

Ariel Rechtman

PFM

SURGE

NEURO

IMMUN

Anirudh Ramachandran United States

Ibrahim E. Efe Germany

S. Bansil United States

Dorlan Kimbrough United States

Sara Salama Egypt

Evaldas Laurenčikas Sweden

Jörg R. Weber Germany

Courtney Casserly Canada

Asaff Harel United States

Gabrielle deCourten-Myers United States

Anirudh Ramachandran United States

Ariel Rechtman

150 ×0.7

PFM

150 ×1.3

SURGE

25 ×0.2

30 ×0.4

NEURO

10 ×0.1

IMMUN

Citations per year, relative to Ariel Rechtman Ariel Rechtman (= 1×) peers Anirudh Ramachandran

Countries citing papers authored by Ariel Rechtman

Since Specialization

Citations

This map shows the geographic impact of Ariel Rechtman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Rechtman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Rechtman more than expected).

Fields of papers citing papers by Ariel Rechtman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Rechtman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Rechtman. The network helps show where Ariel Rechtman may publish in the future.

Co-authorship network of co-authors of Ariel Rechtman

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Rechtman. A scholar is included among the top collaborators of Ariel Rechtman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Rechtman. Ariel Rechtman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rechtman, Ariel, et al.. (2025). Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathway. Frontiers in Immunology. 16. 1620069–1620069.

Rechtman, Ariel, et al.. (2025). Repeated MRI-negative demyelinating attacks linked to MOG-IgG antibodies and silent lesions – Case series and literature review. Clinical Neurology and Neurosurgery. 257. 109111–109111.

Zveik, Omri, Ariel Rechtman, Livnat Brill, & Adi Vaknin‐Dembinsky. (2024). Anti‐ and pro‐inflammatory milieu differentially regulate differentiation and immune functions of oligodendrocyte progenitor cells. Immunology. 171(4). 618–633. 8 indexed citations

Zveik, Omri, et al.. (2024). The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. Molecular Neurodegeneration. 19(1). 53–53. 21 indexed citations

Rechtman, Ariel, et al.. (2024). Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settings. Journal of Neurology. 271(8). 5102–5108. 5 indexed citations

Rechtman, Ariel, et al.. (2024). A protective effect of lower MHC-II expression in MOGAD. Journal of Neuroimmunology. 391. 578351–578351. 1 indexed citations

Zveik, Omri, et al.. (2024). Oligodendrocyte Progenitor Cells Differentiation Induction with MAPK/ERK Inhibitor Fails to Support Repair Processes in the Chronically Demyelinated CNS (P7-6.007). Neurology. 102(17_supplement_1). 1 indexed citations

Rechtman, Ariel, et al.. (2024). Thyroid hormone dysfunction in MOGAD and other demyelinating diseases. Journal of the Neurological Sciences. 457. 122866–122866. 2 indexed citations

Zveik, Omri, et al.. (2024). Subclinical imaging activity in multiple sclerosis patients during war‐related psychological stress. Annals of Clinical and Translational Neurology. 12(1). 17–25. 1 indexed citations

10.

Zveik, Omri, Netta Levin, Livnat Brill, et al.. (2023). Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple Sclerosis. Neurological Sciences. 44(11). 3989–3996. 2 indexed citations

11.

Ganelin‐Cohen, Esther, et al.. (2023). Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implications. Multiple Sclerosis and Related Disorders. 79. 105034–105034. 7 indexed citations

12.

Zveik, Omri, Nina Fainstein, Ariel Rechtman, et al.. (2023). Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS. Glia. 71(12). 2815–2831. 6 indexed citations

13.

Brill, Livnat, et al.. (2022). Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine. Multiple Sclerosis and Related Disorders. 63. 103863–103863. 4 indexed citations

14.

Rechtman, Ariel, et al.. (2022). IL-6 as a marker for NMOSD disease activity. Journal of Neuroimmunology. 370. 577925–577925. 14 indexed citations

15.

Rechtman, Ariel, Livnat Brill, Omri Zveik, et al.. (2022). Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course. Frontiers in Neurology. 13. 867190–867190. 20 indexed citations

16.

Brill, Livnat, Ariel Rechtman, Omri Zveik, et al.. (2021). Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 57. 103343–103343. 14 indexed citations

17.

Brill, Livnat, Ariel Rechtman, Omri Zveik, et al.. (2021). Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab. JAMA Neurology. 78(12). 1510–1510. 102 indexed citations

18.

Rechtman, Ariel, et al.. (1963). Treatment of the Disrupted Radio-Ulnar Joint. Journal of Bone and Joint Surgery. 45(7). 1373–1381. 39 indexed citations

19.

Borden, Alaina, Ariel Rechtman, & J. Gershon‐Cohen. (1960). The Normal Cervical Lordosis. Radiology. 74(5). 806–809. 73 indexed citations

20.

Rechtman, Ariel, et al.. (1956). Common Orthopedic Problems in General Practice. Medical Clinics of North America. 40(5). 1417–1440. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact